Tomorrow the Belgian Galapagos will report its past quarter's results. Over the current book year the total revenue will be 195,65 million euros (consensus estimates). This is hugely more than 2017's revenue of 155,92 million euros.
The analysts expect for 2018 a net loss of 150 million euros. The majority of the analysts expects for this year a loss per share of 2,91 euros. The price-earnings-ratio equals -32,61.
Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals a poor 0,5 percent.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.